If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 1 - 3 of 3
A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)
Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) (SANCTUARY)
Protocol No
NEPH-ALEXION-ALXN1210-202
Categories
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Safety and Efficacy
of OMS721 in Patients with Immunoglobulin A (IgA) Nephropathy (ARTEMIS - IGAN)
Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy
Protocol No
NEPH-ELMEANAWY-OMEROS2
Categories
A Pivotal Phase 3 Trial To Evaluate The Safety And Efficacy Of Clazakizumab For The Treatment Of Chronic Active Antibody-Mediated Rejection In Kidney Transplant Recipients
Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients
Protocol No
NEPH-SAAD-IMAGINE
Categories